Cell Culture Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Diagnostics, Cell & Gene Therapy), By Region, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the cell culture market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for cell culture market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of cell culture market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Cell Culture Market Categorization:

The cell culture market was categorized into three segments, namely product scope (Consumables, Instruments), application (Biopharmaceutical Production, Drug Development, Diagnostics, Tissue Culture & Engineering, Cell & Gene Therapy, Toxicity Testing), region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The cell culture market was segmented into product scope, application, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The cell culture market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Cell culture market companies & financials:

The cell culture market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Sartorius AG - With a global reach, Sartorius AG is divided into two business segments: Bioprocess Solutions and Lab Products & Services. The fast-growing biopharmaceutical sector has been increasingly served by the Lab Products and Services division in recent years. This business division provides its goods to university research institutes and biotech & pharmaceutical research laboratories. The firm provides consumables and instruments to laboratory personnel and researchers. Additionally, it has subsidiaries in more than 30 nations, including Brazil, China, India, Germany, Israel, the United States, and Russia.

• Danaher  - Danaher creates, produces, and sells commercial, medical, and industrial goods and services globally. Three segments make up the company's main product and service offerings: Environmental & Applied Solutions, Life Sciences, and Diagnostics. Its life sciences division provides solutions for filtration, separation, and purification to a range of industries, including biopharmaceuticals, food & beverage, and medical research. In addition, it offers services, consumables, analytical equipment, reagents, and other medical supplies to hospitals, clinics, and other healthcare facilities. Danaher subsidiaries include HemoCue, Leica Biosystems, and Beckman Coulter, Inc.

• Merck KGaA - German multinational Merck KGaA provides medical supplies and solutions. It functions through three domains: performance materials, life sciences, and healthcare. The business has operations throughout Oceania, Africa, Latin America, Europe, Asia, and North America. Products for consumer health, biopharma, allergopharma, biosimilars, life sciences, and performance materials are available. Merck stated in November 2015 that it was purchasing Sigma-Aldrich Co. LLC, a subsidiary.

• Thermo Fisher Scientific, Inc. - Thermo Fisher Scientific, Inc. is a manufacturer and supplier of consumables, analytical instruments, equipment, and diagnostic items for use in laboratories. Several brands, including Fisher Scientific, Invitrogen, Thermo Scientific, Applied Biosystems, and Unity Lab Services, are used by the corporation to do business. Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services are its four reportable segments. Four companies comprise its life sciences solutions segment: genetic sciences, biosciences, bioproduction, and clinical next-generation sequencing. The bioscience business area provides goods such consumables, reagents, cell culture medium, and devices to support clients doing biological and medical research and finding novel medications and vaccines. Hospitals, government organizations, biotechnology and pharmaceutical firms, clinical diagnostics labs, and research institutions are among the clients served by the company.

• Corning Inc. - Corning is divided into a number of business sectors, including hemlock, optical communications, specialized materials, environmental solutions, and new growth companies. The life sciences industry has long been a leader in laboratory product innovation, manufacturing, and international supply. This category provides innovative ways to increase output and facilitate ground-breaking research on traditional small molecules, chemicals, pharmaceuticals, biologics, vaccines, and new cell & gene treatments. Specialized knowledge in the fields of materials science, polymer surface science, cell culture, and cell biology are used to achieve this.

• Avantor, Inc. - A healthcare company called Avantor Inc. (Avantor) produces and sells chemicals, reagents, and lab supplies. Amino acids, silicones, stains, colors, denaturants, silicones, bioreagents, and minerals are among the products that the firm sells. Education, lab & production, sourcing & procurement, laboratory supplies, commercial kitting, digital products for smart science, downstream optimization, and other services are all provided by Avantor.

• BD - Medical technology providers including clinical labs, life sciences researchers, and healthcare organizations and sectors are served by Becton, Dickinson, and Company (BD). The firm produces and distributes a broad variety of laboratory equipment, medical supplies, diagnostic tools, and medical devices. Its operations are divided into three business divisions: BD Life Sciences, BD Medical, and BD Interventional. The BD Life Sciences business offers instruments and reagent systems for the accurate detection of a range of malignancies, infectious diseases, and illnesses linked to healthcare, as well as equipment for the safe collection and transportation of diagnostic samples. Additionally, the firm sells cell culture medium items through its microbiology solutions.

• Eppendorf SE - One of the top companies in the world providing life sciences equipment, supplies, and services for labs handling samples, liquids, and cells is Eppendorf. Dispensers, mixers, centrifuges, spectrometers, and automated pipetting systems are among the products in its lineup. Moreover, university and private research institutes typically use Eppendorf products. For example, biopharmaceutical and biotechnology businesses, as well as the food and chemical sectors.

• Bio-Techne - Bio-Techne Corp is a company that produces, develops, and sells scientific instruments and biotechnology products to help researchers and scientists better understand biological processes. The product line of the company includes instruments, proteins, Luminex tests, enzyme-linked immunosorbent assay (ELISA) kits, Good Manufacturing Products (GMP), and other items. Bio-Techne offers a range of specialized services, including those pertaining to ELISA, chemical libraries, cell & gene therapy, antibodies, targeted protein degradation, licensing, and gene editing.

• PromoCell GmbH - PromoCell GmbH provides optimal cell culture medium, human primary cells, and blood cells. Researchers studying cancer, cardiovascular disease, dermatology, cosmetics, COVID-19, diabetes, obesity, immunooncology, immunology, respiratory disorders, stem cells & regenerative medicine, and 3D cell culture are among its primary end users. These researchers are spread around the globe. The company's goods adhere to biomedical conventions in Europe. It is active in more than 40 nations worldwide.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Cell Culture Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Cell Culture Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.